Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sucralfate pro-epidermal growth factor small molecule NA drugbank Maintenance[MeSHID:D008283]
Gastritis[MeSHID:D005756]
Ulcer[MeSHID:D014456]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]
Duodenal Ulcer[MeSHID:D004381]
Peptic Ulcer[MeSHID:D010437]
Recurrence (disease attribute)[MeSHID:D012008]
Wound Healing[MeSHID:D014945]
Acne Vulgaris[MeSHID:D000152]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved inducer
sucralfate fibrinogen small molecule NA drugbank Maintenance[MeSHID:D008283]
Gastritis[MeSHID:D005756]
Ulcer[MeSHID:D014456]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]
Duodenal Ulcer[MeSHID:D004381]
Peptic Ulcer[MeSHID:D010437]
Recurrence (disease attribute)[MeSHID:D012008]
Wound Healing[MeSHID:D014945]
Acne Vulgaris[MeSHID:D000152]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved binder
sucralfate fibrinogen small molecule NA drugbank Maintenance[MeSHID:D008283]
Gastritis[MeSHID:D005756]
Ulcer[MeSHID:D014456]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]
Duodenal Ulcer[MeSHID:D004381]
Peptic Ulcer[MeSHID:D010437]
Recurrence (disease attribute)[MeSHID:D012008]
Wound Healing[MeSHID:D014945]
Acne Vulgaris[MeSHID:D000152]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved binder
sucralfate fibroblast growth factor 2 small molecule NA drugbank , DGIDB Maintenance[MeSHID:D008283]
Gastritis[MeSHID:D005756]
Ulcer[MeSHID:D014456]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]
Duodenal Ulcer[MeSHID:D004381]
Peptic Ulcer[MeSHID:D010437]
Recurrence (disease attribute)[MeSHID:D012008]
Wound Healing[MeSHID:D014945]
Acne Vulgaris[MeSHID:D000152]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
6.06 approved agonist,inducer
sucralfate fibroblast growth factor-2 NA Successful target TTD , DGIDB Maintenance[MeSHID:D008283]
Gastritis[MeSHID:D005756]
Ulcer[MeSHID:D014456]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]
Duodenal Ulcer[MeSHID:D004381]
Peptic Ulcer[MeSHID:D010437]
Recurrence (disease attribute)[MeSHID:D012008]
Wound Healing[MeSHID:D014945]
Acne Vulgaris[MeSHID:D000152]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
6.06 approved unknown
sucralfate fibrinogen small molecule NA drugbank Maintenance[MeSHID:D008283]
Gastritis[MeSHID:D005756]
Ulcer[MeSHID:D014456]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]
Duodenal Ulcer[MeSHID:D004381]
Peptic Ulcer[MeSHID:D010437]
Recurrence (disease attribute)[MeSHID:D012008]
Wound Healing[MeSHID:D014945]
Acne Vulgaris[MeSHID:D000152]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved binder
sucralfate pepsin a-5 small molecule NA drugbank , DGIDB Maintenance[MeSHID:D008283]
Gastritis[MeSHID:D005756]
Ulcer[MeSHID:D014456]
Dyspepsia[MeSHID:D004415]
Gastroesophageal reflux disease[MeSHID:D005764]
Duodenal Ulcer[MeSHID:D004381]
Peptic Ulcer[MeSHID:D010437]
Recurrence (disease attribute)[MeSHID:D012008]
Wound Healing[MeSHID:D014945]
Acne Vulgaris[MeSHID:D000152]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
84.87 approved inhibitor
click here to return to the previous page